Crestchem Limited (BOM:526269)
83.54
-6.50 (-7.22%)
At close: Mar 27, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 250.62 million as of March 27, 2026. Its market cap has decreased by -61.33% in one year.
Market Cap
250.62M
Enterprise Value
240.16M
Revenue
266.14M
Ranking
n/a
PE Ratio
11.26
Stock Price
83.54
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 250.62M, an increase of 702.50%. That is a compound annual growth rate of 16.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 250.62M | -25.71% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.25B |
| Tyche Industries | 1.10B |
| Resonance Specialties | 1.04B |
| Krebs Biochemicals & Industries | 1.02B |
| Bacil Pharma | 695.69M |
| Alfavision Overseas (India) | 396.91M |
| Vasundhara Rasayans | 349.13M |
| Venmax Drugs and Pharmaceuticals | 306.60M |